NEW YORK, July 29, 2019 /PRNewswire/ --
Vaccine Adjuvants market worldwide is projected to grow by US$516. 85 Thousand, guided by a compounded growth of 10.6%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Particulate Adjuvants, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$304.8 Thousand by the year 2025, Particulate Adjuvants will bring in healthy gains adding significant momentum to global growth. Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN - While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 12.9% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$39.4 Thousand to the region's size and clout in the next 5 to 6 yearsOver US$49.7 Thousand worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Particulate Adjuvants will reach a market size of US$21.6 Thousand by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.9% over the next couple of years and add approximately US$85.7 Thousand in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. - Competitors identified in this market include among others, Agenus, Inc. (USA); Avanti Polar Lipids, Inc. (USA); Brenntag Biosector A/S (Denmark); CSL Ltd. (Australia); Invivogen (USA); Mvp Laboratories Inc. (USA); Novavax, Inc. (USA); OZ Biosciences SAS (France); Seppic SA (France); SPI Pharma (USA)Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN VACCINE ADJUVANTS MARKET ANALYSIS, TRENDS, AND FORECASTS, JULY 2019CONTENTSI. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEWGlobal Competitor Market SharesVaccine Adjuvants Competitor Market Share Scenario Worldwide(in %): 2019 & 2025Global Competitor Market Shares by SegmentParticulate Adjuvants (Type) Global Competitor Market SharePositioning for 2019 & 2025Adjuvant Emulsions (Type) Market Share Breakdown of KeyPlayers: 2019 & 2025Pathogen Components (Type) Competitor Revenue Share (in %):2019 & 2025Combination Adjuvants (Type) Market Share Shift by Company:2019 & 2025Subcutaneous (Route Of Administration) Global Competitor MarketShare Positioning for 2019 & 2025Intramuscular (Route Of Administration) Market Share Breakdownof Key Players: 2019 & 2025Intranasal Route (Route Of Administration) Competitor RevenueShare (in %): 2019 & 2025Oral Route (Route Of Administration) Market Share Shift byCompany: 2019 & 20252. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVETable 1: Vaccine Adjuvants Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 Table 2: Vaccine Adjuvants Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 Table 3: Vaccine Adjuvants Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 Table 4: Research (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025 Table 5: Research (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017 Table 6: Research (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 Table 7: Commercial (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025 Table 8: Commercial (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017 Table 9: Commercial (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 Table 10: Particulate Adjuvants (Type) World Market by Region/Country in US$ Million: 2018 to 2025 Table 11: Particulate Adjuvants (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 Table 12: Particulate Adjuvants (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 Table 13: Adjuvant Emulsions (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 Table 14: Adjuvant Emulsions (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 Table 15: Adjuvant Emulsions (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 Table 16: Pathogen Components (Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 Table 17: Pathogen Components (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 Table 18: Pathogen Components (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 Table 19: Combination Adjuvants (Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 Table 20: Combination Adjuvants (Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 Table 21: Combination Adjuvants (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 Table 22: Other Types (Type) World Market by Region/Country in US$ Million: 2018 to 2025 Table 23: Other Types (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 Table 24: Other Types (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 Table 25: Infectious Diseases (Disease Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 Table 26: Infectious Diseases (Disease Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 Table 27: Infectious Diseases (Disease Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 Table 28: Cancer (Disease Type) World Market by Region/Country in US$ Million: 2018 to 2025 Table 29: Cancer (Disease Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 Table 30: Cancer (Disease Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 Table 31: Other Disease Types (Disease Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025 Table 32: Other Disease Types (Disease Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017 Table 33: Other Disease Types (Disease Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 Table 34: Subcutaneous (Route of Administration) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025 Table 35: Subcutaneous (Route of Administration) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017 Table 36: Subcutaneous (Route of Administration) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 Table 37: Intramuscular (Route of Administration) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025 Table 38: Intramuscular (Route of Administration) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017 Table 39: Intramuscular (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 Table 40: Intranasal Route (Route of Administration) World MARKET by Region/Country in US$ Million: 2018 to 2025 Table 41: Intranasal Route (Route of Administration) Historic MARKET Analysis by Region/Country in US$ Million: 2009 to 2017 Table 42: Intranasal Route (Route of Administration) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 Table 43: Oral Route (Route of Administration) Potential Growth MARKETs Worldwide in US$ Million: 2018 to 2025 Table 44: Oral Route (Route of Administration) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 Table 45: Oral Route (Route of Administration) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 Table 46: Other Route of Administrations (Route of Administration) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 Table 47: Other Route of Administrations (Route of Administration) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 Table 48: Other Route of Administrations (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 Table 49: Human Vaccine Adjuvants (Application Category) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 Table 50: Human Vaccine Adjuvants (Application Category) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 Table 51: Human Vaccine Adjuvants (Application Category) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 Table 52: Veterinary Vaccine Adjuvants (Application Category) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 Table 53: Veterinary Vaccine Adjuvants (Application Category) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 Table 54: Veterinary Vaccine Adjuvants (Application Category) MARKET Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 III. MARKET ANALYSISGEOGRAPHIC MARKET ANALYSIS UNITED STATES MARKET Facts & Figures US Vaccine Adjuvants Market Share (in %) by Company: 2019 & 2025 Particulate Adjuvants (Type) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025 Adjuvant Emulsions (Type) Competitor Revenue Share (in %) in the US: 2019 & 2025 Pathogen Components (Type) Market Share Breakdown (in %) of Major Players in the US: 2019 & 2025 Combination Adjuvants (Type) Market in the US: Percentage Breakdown of Revenues by Company for 2019 & 2025 Subcutaneous (Route Of Administration) Competitor Market Share Breakdown (in %) in the US for 2019 & 2025 Intramuscular (Route Of Administration) Market: Revenue Share Breakdown (in %) of Key Players in the US: 2019 & 2025 Intranasal Route (Route Of Administration) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025 Oral Route (Route Of Administration) Competitor Revenue Share (in %) in the US: 2019 & 2025 Table 55: United States Vaccine Adjuvants Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 Table 56: Vaccine Adjuvants Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017 Table 57: Vaccine Adjuvants Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 Table 58: United States Vaccine Adjuvants Market Estimates and Projections in US$ Million by Type: 2018 to 2025 Table 59: Vaccine Adjuvants Market in the United States by Type: A Historic Review in US$ Million for 2009-2017 Table 60: United States Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025 Table 61: United States Vaccine Adjuvants Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025 Table 62: Vaccine Adjuvants Market in the United States by Disease Type: A Historic Review in US$ Million for 2009-2017 Table 63: United States Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 Table 64: United States Vaccine Adjuvants Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025 Table 65: Vaccine Adjuvants Market in the United States by Route of Administration: A Historic Review in US$ Million for 2009-2017 Table 66: United States Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 Table 67: United States Vaccine Adjuvants Market Estimates and Projections in US$ Million by Application Category: 2018 to 2025 Table 68: Vaccine Adjuvants Market in the United States by Application Category: A Historic Review in US$ Million for 2009-2017 Table 69: United States Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025 CANADA Table 70: Canadian Vaccine Adjuvants Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 Table 71: Vaccine Adjuvants Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 Table 72: Canadian Vaccine Adjuvants Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 73: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 Table 74: Canadian Vaccine Adjuvants Historic Market Review by Type in US$ Million: 2009-2017 Table 75: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 Table 76: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025 Table 77: Canadian Vaccine Adjuvants Historic Market Review by Disease Type in US$ Million: 2009-2017 Table 78: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025 Table 79: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025 Table 80: Canadian Vaccine Adjuvants Historic Market Review by Route of Administration in US$ Million: 2009-2017 Table 81: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025 Table 82: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Application Category: 2018 to 2025 Table 83: Canadian Vaccine Adjuvants Historic Market Review by Application Category in US$ Million: 2009-2017 Table 84: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Application Category for 2009, 2019, and 2025 JAPAN Table 85: Japanese Demand Estimates and Forecasts for Vaccine Adjuvants in US$ Million by Application: 2018 to 2025 Table 86: Japanese Vaccine Adjuvants Market in US$ Million by Application: 2009-2017 Table 87: Vaccine Adjuvants Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 Table 88: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Type for the period 2018-2025 Table 89: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 Table 90: Japanese Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025 Table 91: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Disease Type for the period 2018-2025 Table 92: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017 Table 93: Japanese Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 Table 94: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the period 2018-2025 Table 95: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017 Table 96: Japanese Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 Table 97: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Application Category for the period 2018-2025 Table 98: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Million by Application Category for the Period 2009-2017 Table 99: Japanese Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025 CHINA Table 100: Chinese Demand for Vaccine Adjuvants in US$ Million by Application: 2018 to 2025 Table 101: Vaccine Adjuvants Market Review in China in US$ Million by Application: 2009-2017 Table 102: Chinese Vaccine Adjuvants Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 103: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Million by Type for the Period 2018-2025 Table 104: Vaccine Adjuvants Historic Market Analysis in China in US$ Million by Type: 2009-2017 Table 105: Chinese Vaccine Adjuvants Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 106: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025 Table 107: Vaccine Adjuvants Historic Market Analysis in China in US$ Million by Disease Type: 2009-2017 Table 108: Chinese Vaccine Adjuvants Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 109: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025 Table 110: Vaccine Adjuvants Historic Market Analysis in China in US$ Million by Route of Administration: 2009-2017 Table 111: Chinese Vaccine Adjuvants Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 112: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Million by Application Category for the Period 2018-2025 Table 113: Vaccine Adjuvants Historic Market Analysis in China in US$ Million by Application Category: 2009-2017 Table 114: Chinese Vaccine Adjuvants Market by Application Category: Percentage Breakdown of Sales for 2009, 2019, and 2025 EUROPE MARKET Facts & Figures European Vaccine Adjuvants Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Particulate Adjuvants (Type) Market Share (in %) by Company in Europe: 2019 & 2025 Adjuvant Emulsions (Type) Market Share (in %) of Major Players in Europe: 2019 & 2025 Pathogen Components (Type) Competitor Market Share Analysis (in %) in Europe: 2019 & 2025 Combination Adjuvants (Type) Market in Europe: Competitor Revenue Share Shift (in %) for 2019 & 2025 Subcutaneous (Route Of Administration) Competitor Market Share (in %) Positioning in Europe for 2019 & 2025 Intramuscular (Route Of Administration) Key Player Market Share Breakdown (in %) in Europe: 2019 & 2025 Intranasal Route (Route Of Administration) Market Share (in %) by Company in Europe: 2019 & 2025 Oral Route (Route Of Administration) Market Share (in %) of Major Players in Europe: 2019 & 2025 Table 115: European Vaccine Adjuvants Market Demand Scenario in US$ Million by Region/Country: 2018-2025 Table 116: Vaccine Adjuvants Market in Europe: A Historic MARKET Perspective in US$ Million by Region/Country for the Period 2009-2017 Table 117: European Vaccine Adjuvants Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 Table 118: European Vaccine Adjuvants Addressable Market Opportunity in US$ Million by Application: 2018-2025 Table 119: Vaccine Adjuvants Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 Table 120: European Vaccine Adjuvants Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 121: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Type: 2018-2025 Table 122: Vaccine Adjuvants Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017 Table 123: European Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025 Table 124: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025 Table 125: Vaccine Adjuvants Market in Europe in US$ Million by Disease Type: A Historic Review for the Period 2009-2017 Table 126: European Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 Table 127: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025 Table 128: Vaccine Adjuvants Market in Europe in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017 Table 129: European Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 Table 130: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Application Category: 2018-2025 Table 131: Vaccine Adjuvants Market in Europe in US$ Million by Application Category: A Historic Review for the Period 2009-2017 Table 132: European Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025 FRANCE Table 133: Vaccine Adjuvants Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025 Table 134: French Vaccine Adjuvants Historic Market Review in US$ Million by Application: 2009-2017 Table 135: French Vaccine Adjuvants Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 Table 136: Vaccine Adjuvants Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 137: French Vaccine Adjuvants Historic Market Scenario in US$ Million by Type: 2009-2017 Table 138: French Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025 Table 139: Vaccine Adjuvants Market in France by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 140: French Vaccine Adjuvants Historic Market Scenario in US$ Million by Disease Type: 2009-2017 Table 141: French Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 Table 142: Vaccine Adjuvants Market in France by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025 Table 143: French Vaccine Adjuvants Historic Market Scenario in US$ Million by Route of Administration: 2009-2017 Table 144: French Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 Table 145: Vaccine Adjuvants Market in France by Application Category: Estimates and Projections in US$ Million for the Period 2018-2025 Table 146: French Vaccine Adjuvants Historic Market Scenario in US$ Million by Application Category: 2009-2017 Table 147: French Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025 GERMANY Table 148: Vaccine Adjuvants Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 Table 149: German Vaccine Adjuvants Market in Retrospect in US$ Million by Application: 2009-2017 Table 150: Vaccine Adjuvants Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 Table 151: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 Table 152: German Vaccine Adjuvants Historic Market Analysis in US$ Million by Type: 2009-2017 Table 153: German Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025 Table 154: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025 Table 155: German Vaccine Adjuvants Historic Market Analysis in US$ Million by Disease Type: 2009-2017 Table 156: German Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 Table 157: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025 Table 158: German Vaccine Adjuvants Historic Market Analysis in US$ Million by Route of Administration: 2009-2017 Table 159: German Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 Table 160: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Application Category for the Period 2018-2025 Table 161: German Vaccine Adjuvants Historic Market Analysis in US$ Million by Application Category: 2009-2017 Table 162: German Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025 ITALY Table 163: Italian Demand for Vaccine Adjuvants in US$ Million by Application: 2018 to 2025 Table 164: Vaccine Adjuvants Market Review in Italy in US$ Million by Application: 2009-2017 Table 165: Italian Vaccine Adjuvants Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 166: Italian Vaccine Adjuvants Market Growth Prospects in US$ Million by Type for the Period 2018-2025 Table 167: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Million by Type: 2009-2017 Table 168: Italian Vaccine Adjuvants Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 169: Italian Vaccine Adjuvants Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025 Table 170: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Million by Disease Type: 2009-2017 Table 171: Italian Vaccine Adjuvants Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 172: Italian Vaccine Adjuvants Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025 Table 173: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Million by Route of Administration: 2009-2017 Table 174: Italian Vaccine Adjuvants Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 175: Italian Vaccine Adjuvants Market Growth Prospects in US$ Million by Application Category for the Period 2018-2025 Table 176: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Million by Application Category: 2009-2017 Table 177: Italian Vaccine Adjuvants Market by Application Category: Percentage Breakdown of Sales for 2009, 2019, and 2025 UNITED KINGDOM Table 178: United Kingdom Demand Estimates and Forecasts for Vaccine Adjuvants in US$ Million by Application: 2018 to 2025 Table 179: United Kingdom Vaccine Adjuvants Market in US$ Million by Application: 2009-2017 Table 180: Vaccine Adjuvants Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 Table 181: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Type for the period 2018-2025 Table 182: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 Table 183: United Kingdom Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025 Table 184: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Disease Type for the period 2018-2025 Table 185: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017 Table 186: United Kingdom Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 Table 187: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the period 2018-2025 Table 188: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017 Table 189: United Kingdom Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 Table 190: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Application Category for the period 2018-2025 Table 191: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Application Category for the Period 2009-2017 Table 192: United Kingdom Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025 REST OF EUROPE Table 193: Rest of Europe Vaccine Adjuvants Addressable Market Opportunity in US$ Million by Application: 2018-2025 Table 194: Vaccine Adjuvants Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 Table 195: Rest of Europe Vaccine Adjuvants Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 196: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Type: 2018-2025 Table 197: Vaccine Adjuvants Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017 Table 198: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025 Table 199: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025 Table 200: Vaccine Adjuvants Market in Rest of Europe in US$ Million by Disease Type: A Historic Review for the Period 2009-2017 Table 201: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 Table 202: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025 Table 203: Vaccine Adjuvants Market in Rest of Europe in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017 Table 204: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 Table 205: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Application Category: 2018-2025 Table 206: Vaccine Adjuvants Market in Rest of Europe in US$ Million by Application Category: A Historic Review for the Period 2009-2017 Table 207: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025 ASIA-PACIFIC Table 208: Vaccine Adjuvants Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025 Table 209: Asia-Pacific Vaccine Adjuvants Historic Market Review in US$ Million by Application: 2009-2017 Table 210: Asia-Pacific Vaccine Adjuvants Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 Table 211: Vaccine Adjuvants Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 212: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Million by Type: 2009-2017 Table 213: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025 Table 214: Vaccine Adjuvants Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 215: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Million by Disease Type: 2009-2017 Table 216: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 Table 217: Vaccine Adjuvants Market in Asia-Pacific by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +1 (718) 213 4904 Website: www.reportbuyer.com
Advertisement
Vaccine Adjuvants market worldwide is projected to grow by US$516. 85 Thousand, guided by a compounded growth of 10.6%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Particulate Adjuvants, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$304.8 Thousand by the year 2025, Particulate Adjuvants will bring in healthy gains adding significant momentum to global growth. Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN - While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 12.9% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$39.4 Thousand to the region's size and clout in the next 5 to 6 yearsOver US$49.7 Thousand worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Particulate Adjuvants will reach a market size of US$21.6 Thousand by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.9% over the next couple of years and add approximately US$85.7 Thousand in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. - Competitors identified in this market include among others, Agenus, Inc. (USA); Avanti Polar Lipids, Inc. (USA); Brenntag Biosector A/S (Denmark); CSL Ltd. (Australia); Invivogen (USA); Mvp Laboratories Inc. (USA); Novavax, Inc. (USA); OZ Biosciences SAS (France); Seppic SA (France); SPI Pharma (USA)Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN VACCINE ADJUVANTS MARKET ANALYSIS, TRENDS, AND FORECASTS, JULY 2019CONTENTSI. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEWGlobal Competitor Market SharesVaccine Adjuvants Competitor Market Share Scenario Worldwide(in %): 2019 & 2025Global Competitor Market Shares by SegmentParticulate Adjuvants (Type) Global Competitor Market SharePositioning for 2019 & 2025Adjuvant Emulsions (Type) Market Share Breakdown of KeyPlayers: 2019 & 2025Pathogen Components (Type) Competitor Revenue Share (in %):2019 & 2025Combination Adjuvants (Type) Market Share Shift by Company:2019 & 2025Subcutaneous (Route Of Administration) Global Competitor MarketShare Positioning for 2019 & 2025Intramuscular (Route Of Administration) Market Share Breakdownof Key Players: 2019 & 2025Intranasal Route (Route Of Administration) Competitor RevenueShare (in %): 2019 & 2025Oral Route (Route Of Administration) Market Share Shift byCompany: 2019 & 20252. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVETable 1: Vaccine Adjuvants Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 Table 2: Vaccine Adjuvants Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 Table 3: Vaccine Adjuvants Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 Table 4: Research (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025 Table 5: Research (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017 Table 6: Research (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 Table 7: Commercial (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025 Table 8: Commercial (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017 Table 9: Commercial (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 Table 10: Particulate Adjuvants (Type) World Market by Region/Country in US$ Million: 2018 to 2025 Table 11: Particulate Adjuvants (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 Table 12: Particulate Adjuvants (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 Table 13: Adjuvant Emulsions (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 Table 14: Adjuvant Emulsions (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 Table 15: Adjuvant Emulsions (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 Table 16: Pathogen Components (Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 Table 17: Pathogen Components (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 Table 18: Pathogen Components (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 Table 19: Combination Adjuvants (Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 Table 20: Combination Adjuvants (Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 Table 21: Combination Adjuvants (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 Table 22: Other Types (Type) World Market by Region/Country in US$ Million: 2018 to 2025 Table 23: Other Types (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 Table 24: Other Types (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 Table 25: Infectious Diseases (Disease Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 Table 26: Infectious Diseases (Disease Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 Table 27: Infectious Diseases (Disease Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 Table 28: Cancer (Disease Type) World Market by Region/Country in US$ Million: 2018 to 2025 Table 29: Cancer (Disease Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 Table 30: Cancer (Disease Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 Table 31: Other Disease Types (Disease Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025 Table 32: Other Disease Types (Disease Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017 Table 33: Other Disease Types (Disease Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 Table 34: Subcutaneous (Route of Administration) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025 Table 35: Subcutaneous (Route of Administration) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017 Table 36: Subcutaneous (Route of Administration) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 Table 37: Intramuscular (Route of Administration) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025 Table 38: Intramuscular (Route of Administration) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017 Table 39: Intramuscular (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 Table 40: Intranasal Route (Route of Administration) World MARKET by Region/Country in US$ Million: 2018 to 2025 Table 41: Intranasal Route (Route of Administration) Historic MARKET Analysis by Region/Country in US$ Million: 2009 to 2017 Table 42: Intranasal Route (Route of Administration) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 Table 43: Oral Route (Route of Administration) Potential Growth MARKETs Worldwide in US$ Million: 2018 to 2025 Table 44: Oral Route (Route of Administration) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 Table 45: Oral Route (Route of Administration) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 Table 46: Other Route of Administrations (Route of Administration) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 Table 47: Other Route of Administrations (Route of Administration) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 Table 48: Other Route of Administrations (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 Table 49: Human Vaccine Adjuvants (Application Category) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 Table 50: Human Vaccine Adjuvants (Application Category) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 Table 51: Human Vaccine Adjuvants (Application Category) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 Table 52: Veterinary Vaccine Adjuvants (Application Category) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 Table 53: Veterinary Vaccine Adjuvants (Application Category) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 Table 54: Veterinary Vaccine Adjuvants (Application Category) MARKET Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 III. MARKET ANALYSISGEOGRAPHIC MARKET ANALYSIS UNITED STATES MARKET Facts & Figures US Vaccine Adjuvants Market Share (in %) by Company: 2019 & 2025 Particulate Adjuvants (Type) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025 Adjuvant Emulsions (Type) Competitor Revenue Share (in %) in the US: 2019 & 2025 Pathogen Components (Type) Market Share Breakdown (in %) of Major Players in the US: 2019 & 2025 Combination Adjuvants (Type) Market in the US: Percentage Breakdown of Revenues by Company for 2019 & 2025 Subcutaneous (Route Of Administration) Competitor Market Share Breakdown (in %) in the US for 2019 & 2025 Intramuscular (Route Of Administration) Market: Revenue Share Breakdown (in %) of Key Players in the US: 2019 & 2025 Intranasal Route (Route Of Administration) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025 Oral Route (Route Of Administration) Competitor Revenue Share (in %) in the US: 2019 & 2025 Table 55: United States Vaccine Adjuvants Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 Table 56: Vaccine Adjuvants Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017 Table 57: Vaccine Adjuvants Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 Table 58: United States Vaccine Adjuvants Market Estimates and Projections in US$ Million by Type: 2018 to 2025 Table 59: Vaccine Adjuvants Market in the United States by Type: A Historic Review in US$ Million for 2009-2017 Table 60: United States Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025 Table 61: United States Vaccine Adjuvants Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025 Table 62: Vaccine Adjuvants Market in the United States by Disease Type: A Historic Review in US$ Million for 2009-2017 Table 63: United States Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 Table 64: United States Vaccine Adjuvants Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025 Table 65: Vaccine Adjuvants Market in the United States by Route of Administration: A Historic Review in US$ Million for 2009-2017 Table 66: United States Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 Table 67: United States Vaccine Adjuvants Market Estimates and Projections in US$ Million by Application Category: 2018 to 2025 Table 68: Vaccine Adjuvants Market in the United States by Application Category: A Historic Review in US$ Million for 2009-2017 Table 69: United States Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025 CANADA Table 70: Canadian Vaccine Adjuvants Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 Table 71: Vaccine Adjuvants Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 Table 72: Canadian Vaccine Adjuvants Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 73: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 Table 74: Canadian Vaccine Adjuvants Historic Market Review by Type in US$ Million: 2009-2017 Table 75: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 Table 76: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025 Table 77: Canadian Vaccine Adjuvants Historic Market Review by Disease Type in US$ Million: 2009-2017 Table 78: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025 Table 79: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025 Table 80: Canadian Vaccine Adjuvants Historic Market Review by Route of Administration in US$ Million: 2009-2017 Table 81: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025 Table 82: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Application Category: 2018 to 2025 Table 83: Canadian Vaccine Adjuvants Historic Market Review by Application Category in US$ Million: 2009-2017 Table 84: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Application Category for 2009, 2019, and 2025 JAPAN Table 85: Japanese Demand Estimates and Forecasts for Vaccine Adjuvants in US$ Million by Application: 2018 to 2025 Table 86: Japanese Vaccine Adjuvants Market in US$ Million by Application: 2009-2017 Table 87: Vaccine Adjuvants Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 Table 88: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Type for the period 2018-2025 Table 89: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 Table 90: Japanese Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025 Table 91: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Disease Type for the period 2018-2025 Table 92: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017 Table 93: Japanese Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 Table 94: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the period 2018-2025 Table 95: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017 Table 96: Japanese Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 Table 97: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Application Category for the period 2018-2025 Table 98: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Million by Application Category for the Period 2009-2017 Table 99: Japanese Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025 CHINA Table 100: Chinese Demand for Vaccine Adjuvants in US$ Million by Application: 2018 to 2025 Table 101: Vaccine Adjuvants Market Review in China in US$ Million by Application: 2009-2017 Table 102: Chinese Vaccine Adjuvants Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 103: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Million by Type for the Period 2018-2025 Table 104: Vaccine Adjuvants Historic Market Analysis in China in US$ Million by Type: 2009-2017 Table 105: Chinese Vaccine Adjuvants Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 106: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025 Table 107: Vaccine Adjuvants Historic Market Analysis in China in US$ Million by Disease Type: 2009-2017 Table 108: Chinese Vaccine Adjuvants Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 109: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025 Table 110: Vaccine Adjuvants Historic Market Analysis in China in US$ Million by Route of Administration: 2009-2017 Table 111: Chinese Vaccine Adjuvants Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 112: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Million by Application Category for the Period 2018-2025 Table 113: Vaccine Adjuvants Historic Market Analysis in China in US$ Million by Application Category: 2009-2017 Table 114: Chinese Vaccine Adjuvants Market by Application Category: Percentage Breakdown of Sales for 2009, 2019, and 2025 EUROPE MARKET Facts & Figures European Vaccine Adjuvants Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Particulate Adjuvants (Type) Market Share (in %) by Company in Europe: 2019 & 2025 Adjuvant Emulsions (Type) Market Share (in %) of Major Players in Europe: 2019 & 2025 Pathogen Components (Type) Competitor Market Share Analysis (in %) in Europe: 2019 & 2025 Combination Adjuvants (Type) Market in Europe: Competitor Revenue Share Shift (in %) for 2019 & 2025 Subcutaneous (Route Of Administration) Competitor Market Share (in %) Positioning in Europe for 2019 & 2025 Intramuscular (Route Of Administration) Key Player Market Share Breakdown (in %) in Europe: 2019 & 2025 Intranasal Route (Route Of Administration) Market Share (in %) by Company in Europe: 2019 & 2025 Oral Route (Route Of Administration) Market Share (in %) of Major Players in Europe: 2019 & 2025 Table 115: European Vaccine Adjuvants Market Demand Scenario in US$ Million by Region/Country: 2018-2025 Table 116: Vaccine Adjuvants Market in Europe: A Historic MARKET Perspective in US$ Million by Region/Country for the Period 2009-2017 Table 117: European Vaccine Adjuvants Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 Table 118: European Vaccine Adjuvants Addressable Market Opportunity in US$ Million by Application: 2018-2025 Table 119: Vaccine Adjuvants Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 Table 120: European Vaccine Adjuvants Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 121: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Type: 2018-2025 Table 122: Vaccine Adjuvants Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017 Table 123: European Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025 Table 124: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025 Table 125: Vaccine Adjuvants Market in Europe in US$ Million by Disease Type: A Historic Review for the Period 2009-2017 Table 126: European Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 Table 127: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025 Table 128: Vaccine Adjuvants Market in Europe in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017 Table 129: European Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 Table 130: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Application Category: 2018-2025 Table 131: Vaccine Adjuvants Market in Europe in US$ Million by Application Category: A Historic Review for the Period 2009-2017 Table 132: European Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025 FRANCE Table 133: Vaccine Adjuvants Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025 Table 134: French Vaccine Adjuvants Historic Market Review in US$ Million by Application: 2009-2017 Table 135: French Vaccine Adjuvants Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 Table 136: Vaccine Adjuvants Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 137: French Vaccine Adjuvants Historic Market Scenario in US$ Million by Type: 2009-2017 Table 138: French Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025 Table 139: Vaccine Adjuvants Market in France by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 140: French Vaccine Adjuvants Historic Market Scenario in US$ Million by Disease Type: 2009-2017 Table 141: French Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 Table 142: Vaccine Adjuvants Market in France by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025 Table 143: French Vaccine Adjuvants Historic Market Scenario in US$ Million by Route of Administration: 2009-2017 Table 144: French Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 Table 145: Vaccine Adjuvants Market in France by Application Category: Estimates and Projections in US$ Million for the Period 2018-2025 Table 146: French Vaccine Adjuvants Historic Market Scenario in US$ Million by Application Category: 2009-2017 Table 147: French Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025 GERMANY Table 148: Vaccine Adjuvants Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 Table 149: German Vaccine Adjuvants Market in Retrospect in US$ Million by Application: 2009-2017 Table 150: Vaccine Adjuvants Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 Table 151: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 Table 152: German Vaccine Adjuvants Historic Market Analysis in US$ Million by Type: 2009-2017 Table 153: German Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025 Table 154: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025 Table 155: German Vaccine Adjuvants Historic Market Analysis in US$ Million by Disease Type: 2009-2017 Table 156: German Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 Table 157: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025 Table 158: German Vaccine Adjuvants Historic Market Analysis in US$ Million by Route of Administration: 2009-2017 Table 159: German Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 Table 160: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Application Category for the Period 2018-2025 Table 161: German Vaccine Adjuvants Historic Market Analysis in US$ Million by Application Category: 2009-2017 Table 162: German Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025 ITALY Table 163: Italian Demand for Vaccine Adjuvants in US$ Million by Application: 2018 to 2025 Table 164: Vaccine Adjuvants Market Review in Italy in US$ Million by Application: 2009-2017 Table 165: Italian Vaccine Adjuvants Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 166: Italian Vaccine Adjuvants Market Growth Prospects in US$ Million by Type for the Period 2018-2025 Table 167: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Million by Type: 2009-2017 Table 168: Italian Vaccine Adjuvants Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 169: Italian Vaccine Adjuvants Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025 Table 170: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Million by Disease Type: 2009-2017 Table 171: Italian Vaccine Adjuvants Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 172: Italian Vaccine Adjuvants Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025 Table 173: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Million by Route of Administration: 2009-2017 Table 174: Italian Vaccine Adjuvants Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 175: Italian Vaccine Adjuvants Market Growth Prospects in US$ Million by Application Category for the Period 2018-2025 Table 176: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Million by Application Category: 2009-2017 Table 177: Italian Vaccine Adjuvants Market by Application Category: Percentage Breakdown of Sales for 2009, 2019, and 2025 UNITED KINGDOM Table 178: United Kingdom Demand Estimates and Forecasts for Vaccine Adjuvants in US$ Million by Application: 2018 to 2025 Table 179: United Kingdom Vaccine Adjuvants Market in US$ Million by Application: 2009-2017 Table 180: Vaccine Adjuvants Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 Table 181: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Type for the period 2018-2025 Table 182: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 Table 183: United Kingdom Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025 Table 184: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Disease Type for the period 2018-2025 Table 185: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017 Table 186: United Kingdom Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 Table 187: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the period 2018-2025 Table 188: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017 Table 189: United Kingdom Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 Table 190: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Million by Application Category for the period 2018-2025 Table 191: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Application Category for the Period 2009-2017 Table 192: United Kingdom Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025 REST OF EUROPE Table 193: Rest of Europe Vaccine Adjuvants Addressable Market Opportunity in US$ Million by Application: 2018-2025 Table 194: Vaccine Adjuvants Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 Table 195: Rest of Europe Vaccine Adjuvants Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 196: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Type: 2018-2025 Table 197: Vaccine Adjuvants Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017 Table 198: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025 Table 199: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025 Table 200: Vaccine Adjuvants Market in Rest of Europe in US$ Million by Disease Type: A Historic Review for the Period 2009-2017 Table 201: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 Table 202: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025 Table 203: Vaccine Adjuvants Market in Rest of Europe in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017 Table 204: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 Table 205: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Million by Application Category: 2018-2025 Table 206: Vaccine Adjuvants Market in Rest of Europe in US$ Million by Application Category: A Historic Review for the Period 2009-2017 Table 207: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025 ASIA-PACIFIC Table 208: Vaccine Adjuvants Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025 Table 209: Asia-Pacific Vaccine Adjuvants Historic Market Review in US$ Million by Application: 2009-2017 Table 210: Asia-Pacific Vaccine Adjuvants Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 Table 211: Vaccine Adjuvants Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 212: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Million by Type: 2009-2017 Table 213: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025 Table 214: Vaccine Adjuvants Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 215: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Million by Disease Type: 2009-2017 Table 216: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 Table 217: Vaccine Adjuvants Market in Asia-Pacific by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +1 (718) 213 4904 Website: www.reportbuyer.com
Advertisement
View original content:http://www.prnewswire.com/news-releases/global-vaccine-adjuvants-industry-300892488.html
SOURCE ReportBuyer
